Immunocellular Therapeutics Overview
- Founded
-
1987
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
IMUC
- Investments
-
2
- Share Price
-
$0.65
- (As of Thursday Closing)
Immunocellular Therapeutics General Information
Description
ImmunoCellular Therapeutics Ltd is seeking to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
Contact Information
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
- 18375 Ventura Boulveard
- Suite 381
- Tarzana, CA 91356
- United States
+1 (818) 000-0000
Immunocellular Therapeutics Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.65 | $0.66 | $0.14 - $0.75 | 7.15K |
Immunocellular Therapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 |
|---|---|---|---|---|
| EV | 5,871 | 5,116 | (5,895) | 7,652 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (5,650) | (13,386) | (20,723) | (12,641) |
| Net Income | (5,664) | (14,312) | (22,086) | (12,791) |
| Total Assets | 3,829 | 7,009 | 16,890 | 30,082 |
| Total Debt | 0 | 0 | 574 | 1,959 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Immunocellular Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Immunocellular Therapeutics Patents
Immunocellular Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2898474-A1 | Cancer vaccines and vaccination methods | Abandoned | 14-Feb-2013 | 00000000000 | |
| EP-2956544-A1 | Cancer vaccines and vaccination methods | Granted | 14-Feb-2013 | 00000000000 | |
| CA-2898457-A1 | Ovarian cancer vaccines and vaccination methods | Abandoned | 14-Feb-2013 | 00000000000 | |
| EP-2956164-A1 | Ovarian cancer vaccines and vaccination methods | Withdrawn | 14-Feb-2013 | 00000000000 | |
| EP-2956164-A4 | Ovarian cancer vaccines and vaccination methods | Withdrawn | 14-Feb-2013 | A61K39/0011 | 0 |
Immunocellular Therapeutics Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gary Titus | Chairman & Board Member |
Immunocellular Therapeutics Board Members (16)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 00000 | Immunocellular Therapeutics | Chairman & Board Member | 000 0000 |
| 0000 00 00 | Immunocellular Therapeutics | Board Member | 000 0000 |
Immunocellular Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Immunocellular Therapeutics Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 000000000 | 02-Dec-2021 | 0000000 00 | Biotechnology | 0000 0000 | |
| Molecular Discoveries (Monoclonal Antibody Related Technology) | 14-Feb-2008 | Corporate Asset Purchase | Buildings and Property |